Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
PDCD10 encodes an evolutionarily conserved protein associated with cell apoptosis.
Showing 10 out of 68 products:
The identified endothelial signalling pathway of CCM3-DLL4 (Montrer DLL4 Anticorps)/Notch (Montrer NOTCH1 Anticorps)-EphB4 (Montrer EPHB4 Anticorps)-Erk1/2 may provide an insight into mechanism of CCM3-ablation-mediated angiogenesis.
Case-control study to investigate the possible association of others polymorphisms (c.485+65 C/G, c.989+63 C/G, c.1980 A/G in CCM1 (Montrer KRIT1 Anticorps) gene, c.472+127 C/T in CCM2 (Montrer CCM2 Anticorps) and c.150 G/A in CCM3) with cerebral cavernous malformations. The five polymorphisms were characterized in 64 sporadic patients and in 90 healthy controls by ASO-PCR. Results suggest that some polymorphisms in CCM genes could play an important role in the disease.
CCM3 restrains ANGPT2 (Montrer UNC13B Anticorps)release from endothelial cells and maintains endot (Montrer VAMP3 Anticorps)helial junctions. CCM3 depletion leads to increa (Montrer ANGPT2 Anticorps)sed ANGPT2 release.
Data indicated that rs9853967 and rs11714980 polymorphisms in CCM3 and SERPINI1respectively could be associated with a protective role in cerebral cavernous malformations disease.
Inhibition of Notch (Montrer NOTCH1 Anticorps) and activation of VEGF (Montrer VEGFA Anticorps)/p38 (Montrer CRK Anticorps) signaling were involved in miR (Montrer MLXIP Anticorps)-425-5p/CCM3 mediated inhibition of angiogenesis by sodium arsenite.
Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Studies suggest that the 3 proteins of the Cerebral Cavernous Malformations (CCM) complex KRIT1/CCM1 (Montrer KRIT1 Anticorps), CCM2/malcavernin (Montrer CCM2 Anticorps) and CCM3/PDCD10 not only require one another for reciprocal stabilization, but also act as a platform for signal transduction.
Study highlights the potential role of CCM3 in regulating tight junction complex organization and brain endothelial barrier permeability through CCM3-ERK1/2-cortactin (Montrer CTTN Anticorps) cross-talk
A novel CCM3 missense mutation (c.422T>G) detected in 2 Greek brothers with cerebral cavernous malformations causes a loss of function in Pdcd10 protein due to its localization in the 8th helix. It affects Leu141. It may play a role in angiogenesis.
The proto-oncogene (Montrer RAB1A Anticorps) PDCD10 is direct target of miR (Montrer MLXIP Anticorps)-103 that can suppress Prostate cancer proliferation and migration by down-regulating the PDCD10.
CCM3 suppresses UNC13B (Montrer UNC13B Anticorps)- and vesicle-associated membrane protein 3 (VAMP3 (Montrer VAMP3 Anticorps))-dependent exocytosis of angiopoietin 2 (ANGPT2 (Montrer ANGPT2 Anticorps)) in brain endothelial cells. CCM3 deficiency in endothelial cells augments the exocytosis and secretion of ANGPT2 (Montrer ANGPT2 Anticorps), which is associated with destabilized endothelial cell junctions, enlarged lumen formation and endothelial cell-pericyte dissociation.
CCM3 expression and it's role during ovary and testis development
Study shows that PDCD10 mutations result in vascular permeability mediated by ROCK activity and a particularly severe clinical phenotype of patients and mouse model for cerebral cavernous malformation disease.
Data show that sulindac sulfide (Montrer SQRDL Anticorps) and sulindac sulfone, which attenuate beta-catenin (Montrer CTNNB1 Anticorps) transcription activity, reduce vascular malformations in endothelial programmed cell death 10 protein CCM3-deficient mice.
CCM3 has both cell autonomous and cell non-autonomous functions in neural progenitors and is specifically required in radial glia and newly born pyramidal neurons migrating through the subventricular zone
Although CCM3 stabilizes STK24, it counteracts STK24-mediated inhibition of exocytosis by recruiting STK24 away from the C2B domain through its Ca(2+)-sensitive interaction with UNC13D C2A domain.
Pdcd10 has a different role in cerebral cavernous malformation than Ccm2 (Montrer CCM2 Anticorps) and Krit1 (Montrer KRIT1 Anticorps)
Ccm3 has both neural cell autonomous and nonautonomous functions.
Stabilization of VEGFR2 (Montrer KDR Anticorps) signaling by cerebral cavernous malformation 3 (also known as PDCD10) is critical for vascular development.
This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified.
programmed cell death 10
, TF-1 cell apoptosis-related protein 15
, apoptosis-related protein 15
, cerebral cavernous malformations 3 protein
, programmed cell death protein 10